SS Innovations International, Inc. earnings releases SSII

SS Innovations International, Inc. last reported quarterly results on Aug 13, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $13.9 million (+39.4% year over year) and diluted EPS of -$0.01. It usually reports 13–44 days after a quarter ends. Based on that pattern, the next release is estimated for around Oct 27, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 13–44 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 13, 2026
44 days after quarter end
Q2 FY2026
ended Jun 30, 2026
14
+39.4%
-3
-936.8%
-0.01
May 13, 2026
43 days after quarter end
Q1 FY2026
ended Mar 31, 2026
11
+116.8%
-4
+36.9%
-0.02
+33.3%
Jan 13, 2026
13 days after quarter end
Q4 FY2025
ended Dec 31, 2025
15
+79.1%
-2
-28.5%
-0.01
-14.8%
Oct 28, 2025
28 days after quarter end
Q3 FY2025
ended Sep 30, 2025
13
+192.5%
-4
-14.6%
-0.02
+0.0%
Aug 7, 2025
38 days after quarter end
Q2 FY2025
ended Jun 30, 2025
10
+121.8%
-0
+93.8%
0.00
+100.0%
May 14, 2025
44 days after quarter end
Q1 FY2025
ended Mar 31, 2025
5
+40.8%
-6
+42.3%
-0.03
+50.0%

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SSII (Nasdaq)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Gurugram
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1676163
Former names
SS Innovations International, Inc. (until Oct 26, 2026); AVRA Medical Robotics, Inc. (until Apr 14, 2023)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.